G6PC1 and cancer: We then used UALCAN to evaluate the impact of G6PC expression on patients survival in these types of cancers and the result demonstrated that G6PC had lower expression in KIRC in comparison with normal specimens (P = 3.97E-08), and the lower expression level was related to poor survival rate (P < .0001, Fig. 5C, D).